{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T15:06:39Z","timestamp":1790867199904,"version":"4.1.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2002,6,1]],"date-time":"2002-06-01T00:00:00Z","timestamp":1022889600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Biotechnol"],"published-print":{"date-parts":[[2002,6]]},"DOI":"10.1038\/nbt0602-597","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T08:57:00Z","timestamp":1027673820000},"page":"597-601","source":"Crossref","is-referenced-by-count":245,"title":["Protection against anthrax toxin by recombinant antibody fragments correlates with antigen affinity"],"prefix":"10.1038","volume":"20","author":[{"given":"Jennifer A.","family":"Maynard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catharina B.M.","family":"Maassen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen H.","family":"Leppla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Brasky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean L.","family":"Patterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brent L.","family":"Iverson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Georgiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BFnbt0602597_CR1","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1126\/science.7973702","volume":"266","author":"M Meselson","year":"1994","unstructured":"Meselson, M. et al. The Sverdlosk anthrax outbreak of 1979. Science 266, 1202\u20131208 (1994).","journal-title":"Science"},{"key":"BFnbt0602597_CR2","unstructured":"Anonymous. Investigation of bioterrorism-related anthrax and interim guidelines for clinical evaluation of persons with possible anthrax. Morbid Mortal Weekly Rep. 50, 941\u2013948 (2001)."},{"key":"BFnbt0602597_CR3","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/0264-410X(91)90237-Z","volume":"9","author":"PC Turnbull","year":"1991","unstructured":"Turnbull, P.C. Anthrax vaccines: past, present, and future. Vaccine 9, 536\u2013542 (1991).","journal-title":"Vaccine"},{"key":"BFnbt0602597_CR4","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1056\/NEJM199909093411107","volume":"341","author":"T Dixon","year":"1999","unstructured":"Dixon, T., Meselson, M., Guillemin, J. & Hanna, P. Anthrax. New Engl. J. Med. 341, 815\u2013826 (1999).","journal-title":"New Engl. J. Med."},{"key":"BFnbt0602597_CR5","doi-asserted-by":"publisher","first-page":"933","DOI":"10.3201\/eid0706.010604","volume":"7","author":"J Jernigan","year":"2001","unstructured":"Jernigan, J. et al. Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States. Emerg. Infect. Dis. 7, 933\u2013944 (2001).","journal-title":"Emerg. Infect. Dis."},{"key":"BFnbt0602597_CR6","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1093\/biostatistics\/2.2.233","volume":"2","author":"R Brookmeyer","year":"2001","unstructured":"Brookmeyer, R., Blades, N., Hugh-Jones, M. & Henderson, D. The statistical analysis of truncated data: application to the Sverdlovsk anthrax outbreak. Biostatistics 2, 233\u2013247 (2001).","journal-title":"Biostatistics"},{"key":"BFnbt0602597_CR7","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/n35101999","volume":"414","author":"K Bradley","year":"2001","unstructured":"Bradley, K., Mogridge, J., Mourez, M., Collier, R. & Young, J. Identification of the cellular receptor for anthrax. Nature 414, 225\u2013229 (2001).","journal-title":"Nature"},{"key":"BFnbt0602597_CR8","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/978-3-662-05971-5_19","volume-title":"Bacterial Protein Toxins","author":"S Leppla","year":"2000","unstructured":"Leppla, S. Anthrax toxin. in Bacterial Protein Toxins, Vol. 145 (eds. Aktories, K. & Just, I.) 445\u2013472 (Springer, Berlin, 2000)."},{"key":"BFnbt0602597_CR9","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1038\/nbt1001-958","volume":"19","author":"M Mourez","year":"2001","unstructured":"Mourez, M. et al. Designing a polyvalent inhibitor of anthrax toxin. Nat. Biotechnol. 19, 958\u2013961 (2001).","journal-title":"Nat. Biotechnol."},{"key":"BFnbt0602597_CR10","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1099\/13500872-142-3-707","volume":"142","author":"SF Little","year":"1996","unstructured":"Little, S.F. et al. Characterization of lethal factor binding and cell receptor binding domains of protective antigen of Bacillus anthracis using monoclonal antibodies. Microbiology 142, 707\u2013715 (1996).","journal-title":"Microbiology"},{"key":"BFnbt0602597_CR11","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1126\/science.109563","volume":"292","author":"B Sellman","year":"2001","unstructured":"Sellman, B., Mourez, M. & Collier, R. Dominant-negative mutants of a toxin subunit: an approach to therapy of anthrax. Science 292, 695\u2013697 (2001).","journal-title":"Science"},{"key":"BFnbt0602597_CR12","doi-asserted-by":"publisher","first-page":"22090","DOI":"10.1074\/jbc.M010222200","volume":"276","author":"Y Singh","year":"2001","unstructured":"Singh, Y., Khanna, H., Chopra, A. & Mehra, V. A dominant negative mutant of Bacillus anthracis protective antigen inhibits anthrax toxin in vivo. J. Biol. Chem. 276, 22090\u201322094 (2001).","journal-title":"J. Biol. Chem."},{"key":"BFnbt0602597_CR13","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1128\/IAI.56.7.1807-1813.1988","volume":"56","author":"SF Little","year":"1988","unstructured":"Little, S.F., Leppla, S.H. & Cora, E. Production and characterization of monoclonal antibodies to the protective antigen component of Bacillus anthracis toxin. Infect. Immun. 56, 1807\u20131813 (1988).","journal-title":"Infect. Immun."},{"key":"BFnbt0602597_CR14","doi-asserted-by":"crossref","first-page":"5171","DOI":"10.1128\/IAI.65.12.5171-5175.1997","volume":"65","author":"S Little","year":"1997","unstructured":"Little, S., Ivins, B., Fellows, P. & Friedlander, A. Passive protection by polyclonal antibodies against Bacillus anthracis infection in guinea pigs. Infect. Immun. 65, 5171\u20135175 (1997).","journal-title":"Infect. Immun."},{"key":"BFnbt0602597_CR15","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1128\/IAI.70.2.544-550.2002","volume":"70","author":"D Kobiler","year":"2002","unstructured":"Kobiler, D. et al. Efficiency of protection of guinea pigs against infection with Bacillus anthracis spores by passive immunization. Infect. Immun. 70, 544\u2013550 (2002).","journal-title":"Infect. Immun."},{"key":"BFnbt0602597_CR16","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1128\/CMR.13.4.602","volume":"13","author":"M Keller","year":"2000","unstructured":"Keller, M. & Stiehm, E. Passive immunity in prevention and treatment of infectious diseases. Clin. Micro. Rev. 13, 602\u2013614 (2000).","journal-title":"Clin. Micro. Rev."},{"key":"BFnbt0602597_CR17","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/nbt0202-114","volume":"20","author":"A Casadevall","year":"2002","unstructured":"Casadevall, A. Antibodies for defense against biological attack. Nat. Biotechnol. 20, 114 (2002).","journal-title":"Nat. Biotechnol."},{"key":"BFnbt0602597_CR18","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1086\/514115","volume":"176","author":"S Johnson","year":"1997","unstructured":"Johnson, S. et al. Development of a humanized monoclonal antibody (MEDI-493) with potent in vitro and in vivo activity against respiratory syncitial virus. J. Infect. Dis. 176, 1215\u20131224 (1997).","journal-title":"J. Infect. Dis."},{"key":"BFnbt0602597_CR19","doi-asserted-by":"publisher","first-page":"4768","DOI":"10.1016\/S0264-410X(01)00234-1","volume":"19","author":"M Pitt","year":"2001","unstructured":"Pitt, M. et al. In vitro correlate of immunity in a rabbit model of inhalational anthrax. Vaccine 19, 4768\u20134773 (2001).","journal-title":"Vaccine"},{"key":"BFnbt0602597_CR20","doi-asserted-by":"publisher","first-page":"2888","DOI":"10.1128\/IAI.69.5.2888-2893.2001","volume":"69","author":"S Reuveny","year":"2001","unstructured":"Reuveny, S. et al. Search for correlates of protective immunity conferred by anthrax vaccine. Infect. Immun. 69, 2888\u20132893 (2001).","journal-title":"Infect. Immun."},{"key":"BFnbt0602597_CR21","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1099\/00221287-147-6-1677","volume":"147","author":"S Welkos","year":"2001","unstructured":"Welkos, S., Little, S., Friedlander, A., Fritz, D. & Fellows, P. The role of antibodies to Bacillus anthracis and anthrax toxin components in inhibiting the early stages of infection by anthrax spores. Microbiology 147, 1677\u20131685 (2001).","journal-title":"Microbiology"},{"key":"BFnbt0602597_CR22","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1006\/abio.1995.1050","volume":"224","author":"M Fromant","year":"1995","unstructured":"Fromant, M., Blanquet, S. & Plateau, P. Direct random mutagenesis of gene sized DNA fragments using polymerase chain reaction. Anal. Biochem. 224, 347\u2013353 (1995).","journal-title":"Anal. Biochem."},{"key":"BFnbt0602597_CR23","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/370389a0","volume":"370","author":"WPC Stemmer","year":"1994","unstructured":"Stemmer, W.P.C. Rapid evolution of a protein in vitro by DNA shuffling. Nature 370, 389\u2013391 (1994).","journal-title":"Nature"},{"key":"BFnbt0602597_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1006\/prep.1999.1164","volume":"18","author":"A Hayhurst","year":"1999","unstructured":"Hayhurst, A. Improved expression characteristics of single chain Fv fragments when fused downstream of the E. coli maltose binding protein or upstream of a single immunoglobulin constant domain. Protein. Expr. Purif. 18, 1\u201310 (1999).","journal-title":"Protein. Expr. Purif."},{"key":"BFnbt0602597_CR25","first-page":"4750","volume":"61","author":"G Adams","year":"2001","unstructured":"Adams, G. et al. High affinity restricts the localization and tumor penetration of single-chain Fv antibodies. Cancer Res. 61, 4750\u20134755 (2001).","journal-title":"Cancer Res."},{"key":"BFnbt0602597_CR26","doi-asserted-by":"publisher","first-page":"4285","DOI":"10.1073\/pnas.89.10.4285","volume":"89","author":"P Carter","year":"1992","unstructured":"Carter, P. et al. Humanization of an anti-p185\/HER2 antibody for human cancer therapy. Proc. Natl. Acad. Sci. USA 89, 4285\u20134289 (1992).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnbt0602597_CR27","doi-asserted-by":"publisher","first-page":"14385","DOI":"10.1074\/jbc.M011669200","volume":"276","author":"J Willuda","year":"2001","unstructured":"Willuda, J. et al. Tumor targeting of mono-, di-, and tetravalent anti-p185HER2 miniantibodies multimerized by self associating peptides. J. Biol. Chem. 276, 14385\u201314392 (2001).","journal-title":"J. Biol. Chem."},{"key":"BFnbt0602597_CR28","doi-asserted-by":"publisher","first-page":"23373","DOI":"10.1074\/jbc.270.40.23373","volume":"270","author":"I Benhar","year":"1995","unstructured":"Benhar, I. & Pastan, I. Identification of residues that stabilize the single-chain Fv of monoclonal antibodies B3. J. Biol. Chem. 270, 23373\u201323380 (1995).","journal-title":"J. Biol. Chem."},{"key":"BFnbt0602597_CR29","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1002\/(SICI)1097-0215(19980413)76:2<232::AID-IJC11>3.0.CO;2-E","volume":"76","author":"W Helfrich","year":"1998","unstructured":"Helfrich, W. et al. Construction and characterization of a bispecific diabody for retargeting T cells to human carcinomas. Int. J. Cancer 76, 232\u2013239 (1998).","journal-title":"Int. J. Cancer"},{"key":"BFnbt0602597_CR30","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1093\/protein\/10.4.435","volume":"10","author":"L Nieba","year":"1997","unstructured":"Nieba, L., Honegger, A., Krebber, C. & Pluckthun, A. Disrupting the hydrophobic patches at the antibody variable\/constant domain interface: improved in vivo folding and physical characterization of an engineered scFv fragment. Protein Eng. 10, 435\u2013444 (1997).","journal-title":"Protein Eng."},{"key":"BFnbt0602597_CR31","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1073\/pnas.98.1.75","volume":"98","author":"L Jermutus","year":"2001","unstructured":"Jermutus, L., Honegger, A., Schwesinger, F., Hanes, J. & Pluckthun, A. Tailoring in vitro evolution for protein affinity or stability. Proc. Natl. Acad. Sci. USA 98, 75\u201380 (2001).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnbt0602597_CR32","first-page":"6363","volume":"51","author":"DE Milenic","year":"1991","unstructured":"Milenic, D.E. et al. Construction, binding properties, metabolism, and tumor-targeting of a single-chain Fv derived from the pancarcinoma monoclonal antibody CC49. Cancer Res. 51, 6363\u20136371 (1991).","journal-title":"Cancer Res."},{"key":"BFnbt0602597_CR33","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1128\/IAI.59.10.3381-3386.1991","volume":"59","author":"V Escuyer","year":"1991","unstructured":"Escuyer, V. & Collier, R.J. Anthrax protective antigen interacts with a specific receptor on the surface of CHO-K1 cells. Infect. Immun. 59, 3381\u20133386 (1991).","journal-title":"Infect. Immun."},{"key":"BFnbt0602597_CR34","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1128\/AEM.55.8.2098-2100.1989","volume":"55","author":"B Ivins","year":"1989","unstructured":"Ivins, B., Ristroph, J. & Nelson, G. Influence of body weight on response of Fischer 344 rats to anthrax lethal toxin. Appl. Enviro. Micro. 55, 2098\u20132100 (1989).","journal-title":"Appl. Enviro. Micro."},{"key":"BFnbt0602597_CR35","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1128\/IAI.45.3.761-767.1984","volume":"45","author":"JW Ezzell","year":"1984","unstructured":"Ezzell, J.W., Ivins, B.E. & Leppla, S.H. Immunoelectrophoretic analysis, toxicity, and kinetics of in vitro production of the protective antigen and lethal factor components of Bacillus anthracis toxin. Infect. Immun. 45, 761\u2013767 (1984).","journal-title":"Infect. Immun."},{"key":"BFnbt0602597_CR36","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S0022-1759(96)00208-6","volume":"201","author":"A Krebber","year":"1997","unstructured":"Krebber, A. et al. Reliable cloning of functional antibody variable domains from hybridomas and spleen cell repertoires employing a reengineered phage display system. J. Immunol. Methods 201, 35\u201355 (1997).","journal-title":"J. Immunol. Methods"},{"key":"BFnbt0602597_CR37","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1006\/prep.1999.1035","volume":"15","author":"A Hayhurst","year":"1999","unstructured":"Hayhurst, A. & Harris, W.J. Escherichia coli skp chaperone coexpression improves solubility and phage display of single-chain antibody fragments. Protein Expr. Purif. 15, 336\u2013343 (1999).","journal-title":"Protein Expr. Purif."},{"key":"BFnbt0602597_CR38","volume-title":"Antibodies: A Laboratory Manual","author":"E Harlow","year":"1988","unstructured":"Harlow, E. & Lane, D. Antibodies: A Laboratory Manual (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1988)."},{"key":"BFnbt0602597_CR39","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/protein\/12.4.349","volume":"12","author":"G Chen","year":"1999","unstructured":"Chen, G., Dubrawsky, I., Mendez, P., Georgiou, G. & Iverson, B.L. In vitro scanning saturation mutagenesis of all the specificity determining residues in an antibody binding site. Protein Eng. 12, 349\u2013356 (1999).","journal-title":"Protein Eng."},{"key":"BFnbt0602597_CR40","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/0167-7799(90)90146-O","volume":"8","author":"CN Pace","year":"1990","unstructured":"Pace, C.N. Measuring and increasing protein stability. Trends Biotechnol. 8, 93\u201398 (1990).","journal-title":"Trends Biotechnol."},{"key":"BFnbt0602597_CR41","first-page":"311","volume-title":"Protein Structure: A Practical Approach","author":"C Pace","year":"1989","unstructured":"Pace, C., Shirley, B. & Thomson, J. Measuring the conformational stability of a protein. in Protein Structure: A Practical Approach (ed. Creighton, T.) 311\u2013330 (IRL, New York, 1989)."},{"key":"BFnbt0602597_CR42","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/BF03401732","volume":"4","author":"M Varughese","year":"1998","unstructured":"Varughese, M. et al. Internalization of a Bacillus anthracis protective antigen-c-Myc fusion protein mediated by cell surface anti-c-Myc antibodies. Molec. Med. 4, 87\u201395 (1998).","journal-title":"Molec. Med."},{"key":"BFnbt0602597_CR43","first-page":"371","volume":"288","author":"YS Lin","year":"1999","unstructured":"Lin, Y.S. et al. Preclinical pharmacokinetics, interspecies scaling, and tissue distribution of a humanized monoclonal antibody against vascular endothelial growth factor. J. Pharm. Exp. Ther. 288, 371\u2013378 (1999).","journal-title":"J. Pharm. Exp. Ther."}],"container-title":["Nature Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nbt0602-597.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nbt0602-597","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nbt0602-597.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T19:55:16Z","timestamp":1684439716000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nbt0602-597"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,6]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2002,6]]}},"alternative-id":["BFnbt0602597"],"URL":"https:\/\/doi.org\/10.1038\/nbt0602-597","relation":{},"ISSN":["1087-0156","1546-1696"],"issn-type":[{"value":"1087-0156","type":"print"},{"value":"1546-1696","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,6]]}}}